{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T06:56:40Z","timestamp":1768546600422,"version":"3.49.0"},"reference-count":99,"publisher":"Elsevier","isbn-type":[{"value":"9780128122266","type":"print"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/bs.podrm.2017.02.001","type":"book-chapter","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T20:37:51Z","timestamp":1491251871000},"page":"1-90","source":"Crossref","is-referenced-by-count":6,"title":["Cinacalcet Hydrochloride"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.podrm.2017.02.001_bb0005","series-title":"The Merck Index","first-page":"380","year":"2006"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0010","series-title":"Martindale, in: The Complete Drug Reference","author":"Sweetman","year":"2007"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0015","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1517\/13543784.12.8.1413","article-title":"Cinacalcet HCl: a calcimimetic agent for the management of primary and secondary hyperparathyroidism","volume":"12","author":"Franceschini","year":"2003","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0020","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1210\/jc.2002-021597","article-title":"The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism","volume":"88","author":"Shoback","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0025","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0030","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1345\/aph.1D108","article-title":"Calcimimetics and the treatment of primary and secondary hyperparathyroidism","volume":"38","author":"Joy","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/00003495-200565020-00007","article-title":"Cinacalcet hydrochloride","volume":"65","author":"Balfour","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0045","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0050","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.clinthera.2005.11.015","article-title":"Cinacalcet: an oral calcimimetic agent for the management of hyperparathyroidism","volume":"27","author":"Dong","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0055","unstructured":"E.F. Nemeth, B.C. Van Wagenen, M.F. Balandrin, E.G. Delmar, S.T. Moe, Calcium-receptor active molecules, US Patent No. 6,011,068, Jan. 4 (2000)."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0060","unstructured":"B.C. Van Wagenen, S.T. Moe, M.F. Balandrin, E.G. Delmar, E.F. Nemeth, Calcium-receptor active molecules, US 6211244 B1 (2001) through EP 1881954 B1 (2008)."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0065","unstructured":"R. Lifshitz-Liron, Process for the preparation of cinacalcet base, US Patent 7,393,967 B2 July (2008)."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0070","unstructured":"R. Lifshitz-Liron, A. Eisenstadt, S. Wizel, S. Avhar-Maydan, Y. Raizy, R. Ramaty, Process for preparing cinacalcet hydrochloride, EP 1881954 B1 (2008)."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0075","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1080\/00397910801928541","article-title":"Efficient synthesis of cinacalcet hydrochloride","volume":"38","author":"Bijukumar","year":"2008","journal-title":"Synth. Commun."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tetlet.2007.11.030","article-title":"Practical synthesis of the calcimimetic agent, cinacalcet","volume":"49","author":"Thiel","year":"2008","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0085","unstructured":"M. Ferrari, M. Ghezzi, M. Bonaldi, Process for the synthesis of cinacalcet hydrochloride, US 2011\/0105799 A1 (2011) and US 8614354 B2 (2013)."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0090","unstructured":"P. Allegrini, E. Attolino, D. Rossi, A process for the preparation of cinacalcet and intermediates thereof, EP 2327684 A1 (2011)."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0095","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1021\/op200016a","article-title":"Industrial application of Forster reaction: novel one-pot synthesis of cinacalcet hydrochloride, a calcimimetic agent","volume":"15","author":"Shinde","year":"2011","journal-title":"Org. Process Res. Div."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0100","first-page":"1366","article-title":"A novel asymmetric synthesis of cinacalcet hydrochloride","volume":"8","author":"Arava","year":"2012"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0105","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1021\/op300164y","article-title":"A novel method for the large scale synthesis of cinacalcet hydrochloride using iron catalyzed C\u2013C coupling","volume":"16","author":"Tewari","year":"2012","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0110","unstructured":"R. Vlasakova, J. Hajicek, A method of preparing cinacalcet, WO 2013\/075679 A1 (2013)."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0115","unstructured":"R.N. Kankan, D.R. Rao, D.R. Birari, Process for the preparation of cinacalcet and salt thereof, and intermediates for use in the process, US 8,575,393 B2 Nov. (2013)."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0120","first-page":"2291","article-title":"Synthesis of cinacalcet hydrochloride under solvent-free condition","volume":"90","author":"Chavakula","year":"2013","journal-title":"J. Indian Chem. Soc."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0125","unstructured":"R. Chavakula, N.R. Mutyala, S.R. Chennupati, S. Gokaraji, A process for the preparation of cinacalcet hydrochloride and its intermediates, WO 2014016847 A1 (2014)."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0130","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1016\/j.tet.2013.10.014","article-title":"Construction of 3-arylpropylamine using Heck arylation. The total synthesis of cinacalcet hydrochloride, alverine and tolpropamine","volume":"70","author":"Prediger","year":"2014","journal-title":"Tetrahedron"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0135","first-page":"1","article-title":"Synthesis process of cinacalcet hydrochloride","volume":"2","author":"Bian","year":"2014","journal-title":"Hans J. Med. Chem."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0140","unstructured":"N. Catozzi, L. Cotavica, J. Foletto, M. Forcato, R. Viovanetti, G. Soriato, M. Verzini, Process for preparing cinacalcet, US 8,637,708 B2 (2014)."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0145","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1021\/cg8005647","article-title":"Structural and thermodynamic features of crystal polymorphs of (R)-cinacalcet hydrochloride","volume":"8","author":"Braun","year":"2008","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0150","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1039\/b809219b","article-title":"Solid state characterisation of four solvates of R-cinacalcet hydrochloride","volume":"10","author":"Braun","year":"2008","journal-title":"Cryst. Eng. Comm."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0155","series-title":"Solid-State Chemistry of Drugs","author":"Byrn","year":"1999"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1461-5347(98)00062-5","article-title":"Advances in pharmaceutical materials and processing","volume":"1","author":"Morris","year":"1998","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0169-409X(01)00100-4","article-title":"Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes","volume":"48","author":"Morris","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0170","series-title":"Polymorphism in Molecular Crystals","author":"Bernstein","year":"2002"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0175","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/js960238e","article-title":"Spectral methods for the characterization of polymorphs and solvates","volume":"86","author":"Brittain","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0180","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1358\/dof.2002.027.09.695016","article-title":"Cinacalcet hydrochloride","volume":"27","author":"Sorbera","year":"2002","journal-title":"Drugs Future"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0190","unstructured":"Teva Pharmaceutical Industries Ltd., Processes for preparing cinacalcet hydrochloride crystal form I, WO 2006\/127933 A1 (2006)."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0195","unstructured":"Teva Pharmaceutical Industries Ltd., Amorphous cinacalcet hydrochloride and preparation thereof, WO 2006\/127941 A2 (2006)."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0200","unstructured":"Teva Pharmaceutical Industries Ltd., Crystal forms of cinacalcet HCl and processes for their preparation, WO 2007\/062147 A1 (2007)."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0205","unstructured":"Agmen Inc., Methods and compositions for making and using polymorphs of cinacalcet, WO 2007\/112280 A1 (2007)."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0210","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1107\/S0021889899006020","article-title":"WinGX. suite for small-molecule single-crystal crystallography","volume":"32","author":"Farrugia","year":"1999","journal-title":"J. Appl. Cryst."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1107\/S0021889898007717","article-title":"SIR97: a new tool for crystal structure determination and refinement","volume":"32","author":"Altomare","year":"1999","journal-title":"J. Appl. Cryst."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0220","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A short history of SHELX","volume":"A64","author":"Sheldrick","year":"2008","journal-title":"Acta Cryst."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0225","unstructured":"STOE WinXPow 2.10, unpublished (2004)."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0230","series-title":"The Crysfire 2002 System for Automatic Powder Indexing","author":"Shirley","year":"2002"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0235","series-title":"LMGP-Suite of Programs for the Interpretation of X-Ray Experiments","author":"Laugier","year":"2003"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0240","series-title":"FullProf.2k (Version 3.20)","author":"Rodr\u0131guez-Carvajal","year":"2005"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0245","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1524\/zkri.219.12.847.55869","article-title":"A better FOX: using flexible modelling and maximum likelihood to improve direct-space ab initio structure determination from powder diffraction","volume":"219","author":"Favre-Nicolin","year":"2004","journal-title":"Z. Kristallogr."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0250","unstructured":"D.M. Tobbens, H-Master, unpublished."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1107\/S0021889890008391","article-title":"E.s.d'.s and estimated probable error obtained in Rietveld refinements with local correlations","volume":"24","author":"Berar","year":"1991","journal-title":"J. Appl. Cryst."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0260","series-title":"Polymorphism in the Pharmaceutical Industry","first-page":"167","article-title":"Light microscopy","author":"Nichols","year":"2006"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0265","series-title":"Polymorphism in the Pharmaceutical Industry","first-page":"211","article-title":"The importance of solvates","author":"Griesser","year":"2006"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0270","series-title":"The Weak Hydrogen Bond (IUCr Monographs on Crystallography, No. 9)","author":"Desiraju","year":"1999"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0275","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density-functional thermochemistry. III. The role of exact exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0280","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","article-title":"Development of the Colle\u2013Salvetti correlation-energy formula into a functional of the electron density","volume":"B37","author":"Lee","year":"1988","journal-title":"Phys. Rev."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0285","series-title":"Gaussian 03, Revision D.01","author":"Frisch","year":"2004"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0290","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1021\/jp034648k","article-title":"DFT Study of the torsional potential in ethylbenzene and ethoxybenzene: the smallest prototypes of alkyl and alkoxy aryl mesogens","volume":"A107","author":"Cinacchi","year":"2003","journal-title":"J. Phys. Chem."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0300","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1107\/S0108768104020300","article-title":"Novel tools for visualizing and exploring intermolecular interactions in molecular crystals","volume":"B60","author":"McKinnon","year":"2004","journal-title":"Acta Cryst."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0305","series-title":"Crystal Explorer","author":"Wolff","year":"2005"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0310","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1039\/B203191B","article-title":"Fingerprinting intermolecular interactions in molecular crystals","volume":"4","author":"Spackman","year":"2002","journal-title":"Cryst. Eng. Comm."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0315","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF01197380","article-title":"On the polymorphism of pharmaceuticals and other molecular crystals. II. Applicability of thermodynamic rules","volume":"2","author":"Burger","year":"1979","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0320","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF01197379","article-title":"On the polymorphism of pharmaceuticals and other molecular crystals I. Theory of thermodynamic rules","volume":"2","author":"Burger","year":"1979","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0325","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/jps.2600840812","article-title":"Inferring thermodynamic stability relationship of polymorphs from melting data","volume":"84","author":"Yu","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0330","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1021\/ja00471a001","article-title":"Conformational polymorphism. The influence of crystal structure on molecular conformation","volume":"100","author":"Bernstein","year":"1978","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0335","series-title":"Organic Solid State Chemistry","first-page":"471","article-title":"Conformational polymorphism","author":"Bernstein","year":"1987"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0340","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.molstruc.2003.09.002","article-title":"Qualitative and quantitative study of polymorphic forms in drug formulations by near infrared FT-Raman spectroscopy","volume":"661\u2013662","author":"Auer","year":"2003","journal-title":"J. Mol. Struct."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0345","first-page":"111","article-title":"Spectrophotometric determination of cinacalcet hydrochloride in bulk","volume":"2","author":"Manjula","year":"2012","journal-title":"Int. J. Pharm. Rev. Res."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0350","first-page":"513","article-title":"Spectrophotometric estimation of cinacalcet hydrochloride in bulk and tablet dosage form. Intern","volume":"4","author":"Loni","year":"2012","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-153X-6-1","article-title":"Novel spectrophotometric method for determination of cinacalcet hydrochloride in its tablets via derivatization with 1,2-naphthoquinone-4-sulphonate","volume":"6","author":"Darwish","year":"2012","journal-title":"Chem. Cent. J."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0360","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/10739149.2013.832292","article-title":"Determination of cinacalcet hydrochloride by capillary electrophoresis with photodiode array detection","volume":"42","author":"AlShehri","year":"2014","journal-title":"Instrum. Sci. Technol."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0365","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2174\/1573411011309030020","article-title":"A highly sensitive fluorimetric method for determination of cinacalcet hydrochloride in tablets and plasma via derivatization with 7-chloro-4- nitrobenzoxadiazole","volume":"9","author":"Darwish","year":"2013","journal-title":"Curr. Anal. Chem."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0370","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/bmc.1502","article-title":"Indirect reversed-phase high-performance liquid chromatographic and direct thin-layer chromatographic enantioresolution of (R, S)\u2013cinacalcet","volume":"25","author":"Bhushan","year":"2011","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0375","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.5740\/jaoacint.11-351","article-title":"Chiral chromatography studies of chemical behavior of cinacalcet on polysaccharide chiral reversed-phase HPLC stationary phases","volume":"95","author":"Dousa","year":"2012","journal-title":"J. AOAC Int."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0380","first-page":"346","article-title":"Stability-indicating HPLC method for the estimation of cinacalcet hydrochloride API","volume":"1","author":"Manikandan","year":"2013","journal-title":"Indian J. Res. Pharm. Biotechnol."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0385","first-page":"1563","article-title":"A highly sensitive HPLC method with non-extractive sample preparation and UV detection for trace determination of cinacalcet in humam plasma","volume":"8","author":"Darwish","year":"2013","journal-title":"Dig. J. Nanomater. Biostruct."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0390","first-page":"409","article-title":"Validated RP-HPLC method for the estimation of cinacalcet in bulk and tablet dosage form","volume":"3","author":"Tekula","year":"2013","journal-title":"Am. J. PharmTech. Res."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0395","first-page":"990","article-title":"Method development and validation and degradation studies for cinacalcet HCl drug by RP-HPLC method","volume":"2","author":"Bammidi","year":"2014","journal-title":"Int. J. Chem. Pharm. Sci."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0400","first-page":"1216","article-title":"Content determination of cinacalcet hydrochloride tablets by HPLC","volume":"25","author":"Zhao","year":"2014","journal-title":"Zhongguo Yaofang"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0405","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jpba.2011.05.032","article-title":"Quantification of cinacalcet by LC-MS\/MS using liquid-liquid extraction from 50\u03bcL of plasma","volume":"56","author":"Nirogi","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0410","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpba.2011.10.022","article-title":"Determination of cinacalcet hydrochloride in human plasma by liquid chromatography-tandem mass spectrometry","volume":"61","author":"Yang","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0415","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/FTD.0b013e318278dc69","article-title":"Micromethod for quantification of cinacalcet in human plasma by liquid chromatography-tandem mass spectrometry using a stable isotope-labeled internal standard","volume":"35","author":"Cangemi","year":"2013","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0420","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/bmc.3229","article-title":"LC-MS\/MS determination of cinacalcet enantiomers in rat plasma on Chirobiotic V column in polar ionic mode: application to a pharmacokinetic study","volume":"28","author":"Ramisetti","year":"2014","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0425","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1573412909999131125151512","article-title":"Highly sensitive and simple validated ultra-performance liquid chromatography\/tandem mass spectrometry method for the determination of cinacalcet in human plasma","volume":"10","author":"Wani","year":"2014","journal-title":"Curr. Pharm. Anal."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0430","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1039\/c4ay00077c","article-title":"Liquid chromatographic separation, determination and ESI-MS\/MS, FT-IR and NMR characterization of the forced degradation products of cinacalcet","volume":"6","author":"Rao","year":"2014","journal-title":"Anal. Methods"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0435","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1365\/s10337-009-1129-5","article-title":"Avalidated chiral LC method for the enantiomeric separation of cinacalcet hydrochloride","volume":"70","author":"Ravinder","year":"2009","journal-title":"Chromatographia"},{"key":"10.1016\/bs.podrm.2017.02.001_bb0440","first-page":"57","article-title":"Development of validated stability-indicating HPLC method for the determination of cinacalcet hydrochloride and its impurities","volume":"2","author":"Sreedhar","year":"2015","journal-title":"Int. J. Modern. Chem. Appl. Sci."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0445","first-page":"1732","article-title":"A validated LC-MS\/MS method for estimation of cinacalcet in human plasma","volume":"4","author":"Reddy","year":"2015","journal-title":"World J. Pharm. Res."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0450","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3797\/scipharm.1502-06","article-title":"Development and validation of a stability-indicating RP-UPLC method for the estimation of empurities in cinacalcet hydrochloride API and its formulation","volume":"83","author":"Reddy","year":"2015","journal-title":"Sci. Pharm."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0455","first-page":"12","article-title":"Stability-indicating RP-HPLC method for the quantitative analysis of cinacalcet hydrochloride in tablet dosage form","volume":"2015","author":"Dugga","year":"2015","journal-title":"Invent Impact: Pharm. Anal. Quality Assur."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0460","first-page":"454","article-title":"Development and validation RP-HPLC method for estimation of cinacalcet in bulk and tablet dosage form","volume":"5","author":"Ganesh","year":"2015","journal-title":"Am. J. PharmTech. Res."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0465","first-page":"594","article-title":"A new validated liquid chromatographic method for the determination of impurities in cinacalcet hydrochloride","volume":"8","author":"Sigala","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0470","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1124\/dmd.104.000604","article-title":"Metabolism and disposition of calcimimetic agent cinacalcet HCl in humans and animal models","volume":"32","author":"Kumar","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0475","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.ajkd.2004.08.029","article-title":"Pharmacokinetics, pharmacodynamics, and safety of cinacalcet hydrochloride in hemodialysis patients at doses up to 200mg once daily","volume":"44","author":"Harris","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0480","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.103.057273","article-title":"Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl","volume":"308","author":"Nemeth","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0485","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2165\/00003088-200746060-00003","article-title":"Pharmacokinetics of cinacalcet hydrochloride when administered with ketoconazole","volume":"46","author":"Harris","year":"2007","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/bs.podrm.2017.02.001_bb9000","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2165\/00044011-200828100-00004","article-title":"Pharmacokinetics and pharmacodynamics of cinacalcet in hepatic impairment: phase I, open-label, parallel-group, single-dose, single-centre study","volume":"28","author":"Padhi","year":"2008","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0490","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1600-6143.2007.02136.x","article-title":"Pharmacokinetics and pharmacodynamics of cinacalcet in patients with hyperparathyroidism after renal transplantation","volume":"8","author":"Serra","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0495","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00003088-200948050-00002","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of cinacalcet hydrochloride","volume":"48","author":"Padhi","year":"2009","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/bs.podrm.2017.02.001_bb0500","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.clinthera.2012.03.058","article-title":"Pharmacokinetic and pharmacodynamic properties of the calcimimetic agent cinacalcet (KRN1493) in healthy male Korean subjects: a randomized, open-label, single ascending-dose, parallel-group study","volume":"34","author":"Lee","year":"2012","journal-title":"Clin. Ther."}],"container-title":["Profiles of Drug Substances, Excipients and Related Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871512517300018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871512517300018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:32:45Z","timestamp":1761730365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871512517300018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9780128122266"],"references-count":99,"URL":"https:\/\/doi.org\/10.1016\/bs.podrm.2017.02.001","relation":{},"ISSN":["1871-5125"],"issn-type":[{"value":"1871-5125","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}